Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive Proteins

Flagship Pioneering’s newest startup is Expedition Medicines, a company whose artificial intelligence-driven technology platform analyzes the human proteome to learn the chemistry of binding small molecules to protein targets long considered “undruggable.” Expedition already has a cancer drug R&D alliance with Pfizer. The post Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive…

Read More

Public Health Departments Face a Post-Covid Funding Crash

During the coronavirus pandemic, states received a rush of funding from the federal government to bolster their fight against the disease. In many cases, that cash flowed into state and local health departments, fueling a staffing surge to handle, among other things, contact tracing and vaccination efforts. But public health leaders quickly identified a familiar…

Read More

Global COVID-19 Tracker

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.

Read More

Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease

Merida Biosciences is developing antibody-like drugs designed to selectively eliminate disease-driving autoantibodies while sparing healthy components of the immune system. Graves disease, which stems from the immune system’s attack on the thyroid gland, is the startup’s lead disease target. The post Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease appeared…

Read More